Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 18:49:09 - browse：7691

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Medicare drug price negotiation’s day in court

leisure time

WSS

The lessons of Aduhelm, an Alzheimer's drug that was not to be

SCOTUS questions limit to govt efforts to fight misinformation

Health AI adoption puts security, privacy startups on investors' radar

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Covid misinformation case heads to Supreme Court

Nurses recount patients attacks

entertainment

Wikipedia

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Apple Vision Pro: A first look at health apps on the new VR headset

Hepatitis C has a cure — but many Americans still lack access to it

Quicker fix for pulse oximeters urged during FDA public meeting

After affirmative action ruling, medical educators look to 'holistic review'

Covid misinformation case heads to Supreme Court

At least 13 dead in Texas as scorching temps continue

Novo Nordisk to expand supply of Wegovy for U.S. patients

Guidelines to prevent youth baseball injuries need more muscle

The real point of Kenneth Smith’s execution by nitrogen gas

hotspot

Creating egg and sperm cells from stem cells raises ethical issues

Vertigo drug brings hope for rare neuron disorder, Niemann

Cybersecurity threat forces Lurie Children's to take systems offline

Leading voice in opioid treatment defends methadone clinic system

Vertigo drug brings hope for rare neuron disorder, Niemann

Cognito secures funding to test medical device for Alzheimer's

leisure time

entertainment

knowledge

knowledge